A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
NCT 05503797 Brief Summary The objective of this Master Protocol is to…
Read more arrow_forwardNCT 05503797 Brief Summary The objective of this Master Protocol is to…
Read more arrow_forwardNCT 05205109 Brief Summary This is a study of ATG-037 Monotherapy and…
Read more arrow_forwardNCT 06179160 Brief Summary This study is conducted to determine the safety…
Read more arrow_forwardNCT 04913285 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardACTRN 12624001373561 Brief Summary The aim of this study is to determine…
Read more arrow_forwardNCT 05581004 Brief Summary This is a first-in-human study to evaluate the…
Read more arrow_forwardNCT 07115043 Brief Summary A Study to Investigate Safety of AZD6750 in…
Read more arrow_forwardNCT 06326411 Brief Summary This is a two-part Phase 1, open label,…
Read more arrow_forwardNCT 06710847 Brief Summary Solid tumours are abnormal lumps of tissue that…
Read more arrow_forwardNCT 06533059 Brief Summary The purpose of this study is to characterize…
Read more arrow_forward